Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed May 3, 2024 · 10-Q · 33 days after period end · 0001091818-24-000049
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$130.81K | -$130.01K | -$132.41K | -$145.08K |
| EPS Diluted | $0.00 | $0.00 | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 3, 2024 · 33 d after period end
